BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 26, 2009
View Archived Issues
Novel GABA(A) modulator shows antinociceptive activity in vivo
Read More
Biodel to submit NDA for VIAject to FDA for diabetes
Read More
Studies with SAR-150640 show potential importance of ADRB3 agonists in preventing preterm labor
Read More
Studies determine optimal doses of sublingual immunotherapy with rBet v 1
Read More
Combination of paclitaxel and cyclophosphamide is safe in patients with bladder cancer
Read More
DSMB recommends continuation of Anthera's phase II IMPACTS clinical trial of A-001
Read More
Teva to use Compugen biomarkers for detection of drug-induced kidney toxicity
Read More
AVEO and Biogen sign definitive agreement for ErbB3-targeted antibodies
Read More
Gilead initiates phase II cicletanine trial for pulmonary arterial hypertension
Read More
FDA approves new indication for Wyeth's Tygacil
Read More
Novel orally bioavailable alkyl amines display in vivo renin inhibitory activity
Read More
Fablyn approved in Europe for the treatment of osteoporosis
Read More
Clinical study shows potential of kisspeptin-54 as a treatment for infertility
Read More
CV Therapeutics develops candidate SCD inhibitor for obesity, metabolic syndrome and diabetes
Read More
Novel IGF-1R inhibitor BMS-754807 in phase I development
Read More
CFFT grants Alnara exclusive worldwide rights to PERT therapy liprotamase
Read More
Nerviano Medical Sciences claims substituted indazole derivatives as kinase inhibitors
Read More
Oncolytics completes patient enrollment in REO 009 clinical trial of Reolysin and Gemzar
Read More
Novel pyrazoloquinoline and pyrazolonaphthyridine derivatives claimed by Novartis
Read More
HGS and Morphotek sign collaboration agreement for therapeutic monoclonal antibodies
Read More
Novartis claims novel parathyroid calcium-sensing receptor antagonists
Read More
NovaBay and Galderma sign global agreement to develop and commercialize Aganocide
Read More
Abilify oral solution 0.1% to be launched in Japan in April
Read More
Novel alpha-alkyl substituted N-acyltryptophanols discovered by Bayer Schering Pharma
Read More
Additional indication for Actos approved in Japan
Read More
Eisai claims novel polycyclic compounds against beta-amyloid load
Read More
Vertex commences phase II development for VX-809 in cystic fibrosis
Read More